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Polymeric matrices can be used to grow new tissues and organs1,2,
and the delivery of growth factors from these matrices is one
method to regenerate tissues3,4. A problem with engineering
tissues that exist in a mechanically dynamic environment, such
as bone, muscle and blood vessels5,6, is that most drug delivery
systems have been designed to operate under static conditions. We
thought that polymeric matrices, which release growth factors in
response to mechanical signals, might provide a new approach to
guide tissue formation in mechanically stressed environments.
Critical design features for this type of system include the ability
to undergo repeated deformation, and a reversible binding of
the protein growth factors to polymeric matrices to allow for
responses to repeated stimuli. Here we report a model delivery
system that can respond to mechanical signalling and upregulate
the release of a growth factor to promote blood vessel formation.
This approach may ®nd a number of applications, including
regeneration and engineering of new tissues and more general
drug-delivery applications.
Natural extracellular matrices (ECMs) of tissues are regarded as
depots for various growth factors, which are released to cells in the
surrounding tissue to affect many physiological processes7. For
example, release of vascular endothelial growth factor (VEGF)
speci®cally enhances vascularization of tissues8. Synthetic and
naturally derived polymers can be used similarly as depots and
delivery vehicles of protein growth factors9. However, most tissues
in the body are subjected to mechanical stimuli, and this form of
signalling should be considered in the design of polymeric matrices
that release growth factors. We thought that growth factor delivery
could be designed to respond to compressive stimulation of the
matrix, owing to the increased pressure in the carrier resulting from
matrix deformation. This mechanically controlled delivery of
growth factors might allow the local environment of the delivery
device to regulate the local concentration of the factor. This would
be particularly advantageous when using growth factor delivery to
engineer new vascular tissues or bone. We tested this hypothesis
using hydrogel carriers, as hydrogels are frequently used in tissue
engineering10 and are capable of repeated deformation following
compressional loading.
To con®rm that compressional loading can regulate drug release
from polymeric matrices, we prepared alginate hydrogels containing
trypan blue as a model drug molecule and subjected them to repeated
compressive loading using a mechanical tester. The release rate and
cumulative release of the drug increased during each incident of
mechanical loading; however, the cumulative release at the end of
each relaxation period was similar to that of control (non-com-
pressed) hydrogels (see Supplementary Information). In this situa-
tion, hydrogels do not bind this drug, and the mechanical signalling
does not contribute signi®cantly to the release behaviour, owing to
rapid depletion of the incorporated drug from the hydrogel.
We subsequently proposed that reversible binding of drugs to the
hydrogel carrier, similar to the binding of growth factors to natural
ECMs, would allow for a signi®cant effect of cyclic mechanical
stimulation on the factor release. VEGF was chosen as a model
growth factor because of its use in many clinical indications and its
reversible binding interaction with polysaccharides8. In the absence of
mechanical stimulation, the release rate was fairly constant and the
cumulative release of VEGF from the alginate hydrogels increased
linearly with time. However, the release rate under mechanical
stimulation increased to a value up to ®ve times higher than that of
control gels, and this increase could be regulated by the amplitude of
the compression (Fig. 1). In this situation, free drug (not bound)
would be released after each deformation, but the system would re-
equilibrate during the subsequent relaxation by the disassociation of
bound drug from the hydrogel. The cumulative release pro®le showed
a stepwise increment with mechanical signalling, and the total
amount of VEGF released from the hydrogels was up to two times
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Figure 1 In vitro release pro®le of VEGF from alginate hydrogels under mechanical
stimulation. a, Mechanical stimulation involving six cycles of compression for 2 min,
followed by relaxation for 8 min. b, Release rate of VEGF from alginate hydrogels under
10% (n = 4; open circles) and 25% (n = 4; open squares) strain amplitude, and with no
compression (n = 4; ®lled circles) as a control.
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more than that of control conditions, depending on the magnitude
of the mechanical input (see Supplementary Information).
Next, we tested the ability of mechanical stimulation to upregu-
late growth factor release in vivo and affect a local tissue response to
show the ef®cacy and utility of this concept. We used VEGF as a
model factor as it is a potent endothelial-cell-speci®c mitogen; it
also enhances neovascularization, which accompanies many physio-
logical and pathological processes11, resulting in an increase of
granulation tissue thickness and of the number of blood vessels.
We subcutaneously implanted hydrogels loaded with VEGF into the
dorsal region of severe combined immunode®cient (SCID) mice;
we also implanted hydrogels without growth factors as a control. In
the absence of growth factors, no remarkable vascularization
surrounding the implant was observed with or without mechanical
stimulation (Fig. 2a, b). The tissue sections surrounding hydrogels
loaded with VEGF showed enhanced vascularization as expected
(Fig. 2c, d). Notably, VEGF-loaded hydrogels subjected to cyclic
mechanical stimulation showed a statistically signi®cant increase in
granulation layer thickness and in vascularization, as compared with
non-stimulated VEGF-releasing gels. The thickness of granula-
tion tissue surrounding the implants increased from 33 6 8 to
74 6 9 mm (mean 6 s.d. P , 0.01; Fig. 3a), and the number of blood
vessels in the granulation tissue layer increased from 60 6 10 to 91
6 5 under mechanical stimulation (P , 0.05; Fig. 3b).
We investigated this approach further in non-obese diabetic
(NOD) mice, as these diabetic animals are frequently used as an
animal model for impaired wound healing in humans. We
implanted alginate hydrogels containing VEGF into NOD mice
after femoral artery ligation to discern whether an increase in
collateral circulation could be achieved. Blood vessel formation
was quanti®ed after 14 d of implantation, and enhanced blood
vessel formation was observed in mechanically stimulated implant
sites (Fig. 4a, b). The density of blood vessels increased from
161 6 32 to 260 6 65 mm-2 under cyclic mechanical stimulation
(P , 0.05; Fig. 4c). Hydrogels without VEGF were also used as a
control, and no signi®cant blood vessel formation was observed.
Our ®ndings have a number of potential applications for tissue
engineering and drug delivery, and also indicate a new general
mechanism by which tissues in the body may respond to mechanical
signals. It has been proposed that stress-responsive mechanisms
include alterations in cellular structure or metabolism12, and pre-
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Figure 2 In vivo response to VEGF released from alginate hydrogels under mechanical
stimulation. The gels were implanted into the dorsal region of SCID mice for 14 d.
Photomicrographs of representative tissue section from each experimental condition: no
VEGF/no mechanical stimulation (a); no VEGF/mechanical stimulation (b); VEGF
incorporated in hydrogel/no mechanical stimulation (c); and VEGF incorporated in






















































Figure 3 Quantitative analysis of granulation tissue formed in SCID mice. Shown are
thickness of granulation tissue (a) and the number of blood vessels (b) at experimental
conditions of no VEGF/no mechanical stimulation (-/-), no VEGF/mechanical stimulation
(-/+), VEGF incorporated in hydrogel/no mechanical stimulation (+/-) and VEGF
incorporated in hydrogel/mechanical stimulation (+/+) (n = 4). n.s., no statistical
difference. Asterisk indicates statistical signi®cance, P , 0.05. Double asterisk indicates
statistical signi®cance, P , 0.01.
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vious studies that focused on the role of growth factors have detailed
changes in transcription and/or translation of the factors13. It is
possible, perhaps even likely, that the application of mechanical
stress to tissues will lead to an increased release of growth factors
through the mechanism that we describe. This may provide an
important and previously unrecognized means by which stressed
tissues communicate with surrounding tissues, and adapt to their
environment. As such, the systems that we have described here may
be simply mimicking a critical function of natural ECMs. It may also
be possible to develop delivery systems of small drug molecules
using this concept. There have been many attempts to develop drug-
delivery systems in response to external stimuli such as temperature,
pH, ultrasound, and electric or magnetic ®eld14±19. However, little
effort has been devoted to mechanical stimuli-mediated drug-deliv-
ery systems, relative to the signi®cance of these signals in physiolo-
gical situations. This approach could allow a high level of control over
the delivery dose and rate, and might even be incorporated into
feedback systems to allow highly precise delivery pro®les. M
Methods
In vitro release
We prepared alginate hydrogels (10 g, Pronova) containing 63 mg CaSO4, with either
trypan blue (4 mg, Sigma) or VEGF (10 mg, Intergen). We included 125I-labelled VEGF
(Biomedical Technologies) as a tracer in certain experiments. Gels were cut into disks
(12.7 mm diameter and 2 mm thick), and pre-swollen in DMEM overnight. The gel disks
were put into custom-made sample holders (13 mm diameter and 30 mm length) with
porous stainless-steel supports on the top and bottom of the hydrogels to allow the
unimpeded release of the drug from the hydrogel. We compressed the hydrogels with a
mechanical tester (MTS, France), and applied 3±6 cycles of compressive loading (10 or
25% strain; 2-min strain and 8-min relaxation). The amount of released trypan blue was
spectrophotometrically determined at 588 nm. We measured the release of radiolabelled
VEGF by a gamma counter (Packard), and converted it to absolute protein amounts using
the known speci®c activity of 125I-labelled VEGF.
Animal models
Alginate hydrogels (0.5 g) containing 10 mg VEGF and 3.2 mg CaSO4 were cut into disks
(4.8 mm diameter and 2 mm thick) and pre-swollen in DMEM overnight. We anaesthe-
tized animals with an intramuscular injection of 87 mg per ml ketamine and 2.6 mg per ml
xylazine. The gel disks were subcutaneously implanted into the dorsal region of 7±9-week-
old SCID mice in the ®rst model, and a 24-h recovery period was allowed. Disks were
subsequently stimulated daily for 7 d using 50% strain amplitude at three cycles of
compression for 1 min, followed by relaxation for 1 min using a custom-made stimulator.
In the second model, the femoral artery in the right hind limb of 7±9-week-old NOD
mice was ligated and the exposed arterial ends were tied off with nylon sutures. We then
placed a single hydrogel disk directly on the ligation site of each animal and closed the skin
with sutures. Twenty-four hours after surgery, we mechanically stimulated the implan-
tation site daily for 7 d, at six cycles of compression for 30 s, followed by relaxation for 90 s.
The treatment of experimental animals was in accordance with University of Michigan
animal care guidelines, and we observed all NIH animal handling procedures.
After 14 d, the mice in both models were killed and tissues directly surrounding each
implant were taken. The tissues were ®xed in zinc-formalin solution at 4 8C overnight,
dehydrated through graded ethanol, embedded in paraf®n and cut into 4-mm sections. To
identify blood vessels, the tissue sections from SCID mice were stained with haematoxylin
and eosin, and those from NOD mice were immunostained with antibodies raised against
mouse CD31 (Pharmingen) using a terminator blocking solution, universal link
secondary antibody, streptavadin/horseradish peroxidase (HRP) (Biocare Medical) and
3,39-diaminobenzidine (Zymed) as described.20
We quanti®ed the number of blood vessels and the granulation layer thickness by
capturing digital images of tissue sections and analysing them with NIH Image software.
The thickness of the newly formed granulation tissue layer was determined between
hydrogels and muscle layers. Granulation layer thickness and the number of blood vessels
in SCID mice were quanti®ed at ´100 and ´400 magni®cations, respectively, and
normalized by the interfacial length between the hydrogel and the granulation tissue. We
counted the density of blood vessels formed in NOD mice at ´400 magni®cation. We
carried out statistical analysis using Instat software.
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Figure 4 In vivo response to VEGF-loaded hydrogels implanted into femoral artery ligation
site of NOD mice. Shown are photomicrographs of representative tissue section: a, VEGF
incorporated in hydrogel/no mechanical stimulation (+/-); b, VEGF incorporated in
hydrogel/mechanical stimulation (+/+). c, Blood vessel density (number per mm2) at each
experimental condition (n = 4). Control gels without VEGF under static conditions (-/-)
and under mechanical stimulation (-/+) were also implanted. Original magni®cation
´400. Arrows indicate CD31-stained blood vessels. n.s., no statistical difference. Asterisk
indicates statistical signi®cance, P , 0.05.
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